Press/Media
- 375 - 400 out of 3,695 results
Search results
-
Studies from Icahn School of Medicine at Mount Sinai Reveal New Findings on Gastrointestinal Diseases and Conditions (Pleasurable and Problematic Receptive Anal Intercourse and Diseases of the Colon, Rectum and Anus)
Marshall, D., Dickstein, D., Goodman, K., Goldstone, S., Simoes, P., Wong, S.-Y., Buckstein, M., Keefer, L., Sigel, K., Safer, J., Marshall, D. & Avanessian, B.
17/06/24
1 item of Media coverage
Press/Media
-
Tilray Brands Tilray Beverages Announces Campaign to Raise Awareness for Mens Health
Kaplan, S. & Sfakianos, J.
15/06/24
1 item of Media coverage
Press/Media
-
Tilray Beverages Announces Campaign To Raise Awareness For Men'S Health
Kaplan, S. & Sfakianos, J.
14/06/24
1 item of Media coverage
Press/Media
-
Tilray Beverages Announces Campaign to Raise Awareness for Men’s Health
Kaplan, S. & Sfakianos, J.
14/06/24
162 items of Media coverage
Press/Media
-
Australia Patent: ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, CULLINAN ONCOLOGY File Application for 'HETEROBIFUNCTIONAL COMPOUNDS AS HPK1 DEGRADERS'
Sawasdikosol, S., Jin, J. & Burakoff, S.
14/06/24
1 item of Media coverage
Press/Media
-
Tilray Beverages Announces Campaign to Raise Awareness for Men’s Health
Kaplan, S. & Sfakianos, J.
14/06/24
1 item of Media coverage
Press/Media
-
-
Icahn School of Medicine at Mount Sinai Researchers Publish New Data on Epilepsy (Segmentation and quantification of venous structures and perivascular spaces in the thalamus in epilepsy using 7 Tesla MRI)
Verma, G. & Balchandani, P.
11/06/24
1 item of Media coverage
Press/Media
-
Recent Studies from Icahn School of Medicine at Mount Sinai Add New Data to Graft-Versus-Host Disease (Flares of Acute Graft-versus-host Disease: a Mount Sinai Acute Gvhd International Consortium Analysis)
Levine, J. & Akahoshi, Y.
10/06/24
1 item of Media coverage
Press/Media
-
Study Data from Icahn School of Medicine at Mount Sinai Update Knowledge of Bladder Cancer (Induction and Maintenance of Sequential Intravesical Gemcitabine/docetaxel for Intermediate and High-risk Non-muscle Invasive Bladder Cancer With ...)
Ranti, D., Lavallee, E., Mehrazin, R., Etienne, L., Sfakianos, J., Wiklund, P., Attalla, K. & Waingankar, N.
10/06/24
1 item of Media coverage
Press/Media
-
Bispecific antibody delivers positive results in relapsed, refractory multiple myeloma
8/06/24
1 item of Media coverage
Press/Media
-
The National Labor Relations Board (NLRB) Decision: Starbucks Corporation (Case Number: 08-CA-290673)
6/06/24
1 item of Media coverage
Press/Media
-
Research from Icahn School of Medicine at Mount Sinai in Cancer Provides New Insights [Multi-cancer early detection (MCED) tests: prioritizing equity from bench to bedside]
Weber, E., Smith, C., Lin, J., Taioli, E., Villanueva Rodriguez, A., Sly, J. & Mazor, M.
6/06/24
1 item of Media coverage
Press/Media
-
Findings from Icahn School of Medicine at Mount Sinai Reveals New Findings on Cancer (Pan-cancer Proteogenomics Characterization of Tumor Immunity)
Reva, B. A., Sebra, R., Wang, P., Song, X., Ma’ayan, A., Petralia, F. & Chowdhury, S.
4/06/24
1 item of Media coverage
Press/Media
-
Perioperative Chemo Extends Survival in Resectable Esophageal Cancer
3/06/24
1 item of Media coverage
Press/Media
-
Preliminary Analysis Of Data Evaluating Investigational Epcoritamab (Duobody® Cd3xcd20) Combination Demonstrates 95% Overall Response Rate In Patients With Previously Untreated Follicular Lymphoma
2/06/24 → 3/06/24
15 items of Media coverage
Press/Media
-
Preliminary Analysis of Data Evaluating Investigational Epcoritamab (DuoBody® CD3xCD20) Combination Demonstrates 95% Overall Response Rate in Patients with Previously Untreated Follicular Lymphoma
2/06/24 → 3/06/24
3 items of Media coverage
Press/Media
-
MAIC Study Finds Similar Results With Linvoseltamab/Teclistamab in R/R Multiple Myeloma
3/06/24
1 item of Media coverage
Press/Media
-
Flamingo Therapeutics Presents Poster At ASCO 2024 On Phase II PEMDA-HN Trial For Head And Neck Squamous Cell Carcinoma (HNSCC)
2/06/24
158 items of Media coverage
Press/Media
-
Flamingo Therapeutics Presents Poster At ASCO 2024 On Phase II PEMDA-HN Trial For Head And Neck Squamous Cell Carcinoma (HNSCC)
2/06/24
1 item of Media coverage
Press/Media